Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,937
datasets available to search
ShareScore release 0.9.0
Dataset results
2,937 results for “Multiple Myeloma”
Dalteparin, Lenalidomide, and Low-Dose Dexamethasone in Treating Patients With Previously Untreated Multiple Myeloma
ClinicalTrials.gov study NCT01518465. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
ClinicalTrials.gov study NCT07075185. IPD Sharing: YES. Countries: 1. Publications: 0.
Venetoclax and Tocilizumab for the Treatment of Patients With Relapsed or Refractory t(11;14) Multiple Myeloma
ClinicalTrials.gov study NCT05391750. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety and Dose Determining Study of BT062 in Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT00723359. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Real-world Immuno-therapy in Chinese Newly Diagnosed Multiple Myeloma Patients
ClinicalTrials.gov study NCT07296627. IPD Sharing: NO. Countries: 1. Publications: 0.
A Machine Learning Approach to Connect Multiple Myeloma Complexity to Early Disease Recurrence
ClinicalTrials.gov study NCT06767254. IPD Sharing: NO. Countries: 1. Publications: 0.
BCMA and CD19 Targeted Fast Dual CAR-T for BCMA+ Refractory/Relapsed Multiple Myeloma
ClinicalTrials.gov study NCT04236011. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
S9922 Combination Chemo Plus Filgrastim With or Without Thalidomide in Refractory Multiple Myeloma
ClinicalTrials.gov study NCT00005834. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Allogeneic UCB-derived, Dual-targeting BCMA/CD19 CAR-T for Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT07139509. IPD Sharing: YES. Countries: 1. Publications: 0.
Safety and Efficacy Study for the Prevention of Nausea and Vomiting in Multiple Myeloma Patients Receiving Stem Cell Transplantation.
ClinicalTrials.gov study NCT00306735. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase II Randomised Trial of Cyclophosphamide & Dexamethasone in Combination With Ixazomib in Relapsed or Refractory Multiple Myeloma.
ClinicalTrials.gov study NCT02461888. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Efficacy and Safety of Oral CEP-701 for the Treatment of Patients With Advanced Multiple Myeloma
ClinicalTrials.gov study NCT00242827. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Mixed Chimera Allogeneic Transplantation From Matched Unrelated Donors For The Treatment Of Multiple Myeloma
ClinicalTrials.gov study NCT00185653. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CRISPR Delivered Anti-BCMA Car-T Therapy for Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT07340853. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of T Cells Targeting CD19/BCMA (CART-19/BCMA) for High Risk Multiple Myeloma Followed With Auto-HSCT
ClinicalTrials.gov study NCT03455972. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Analysis of the Immune Parameters of COVID-19 Infection in Patients With Multiple Myeloma
ClinicalTrials.gov study NCT04805203. IPD Sharing: NO. Countries: 1. Publications: 0.
Vaccination in the Peripheral Stem Cell Transplant Setting for Multiple Myeloma
ClinicalTrials.gov study NCT00116441. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Integrating Touchscreen-based Geriatric Assessment and Frailty Screening for Adults With Multiple Myeloma
ClinicalTrials.gov study NCT03068637. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase 2 Study of Radiotherapy-induced Immune Priming to Enhance Elranatamab (Elra) in Relapsed Refractory Multiple Myeloma (RRMM) With Extramedullary Disease (EMD) and Paramedullary Disease (PMD) "P
ClinicalTrials.gov study NCT07382739. IPD Sharing: Not stated. Countries: 1. Publications: 0.
S0833, Bortezomib, Thalidomide, Lenalidomide, Combination Chemotherapy, and Autologous Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma
ClinicalTrials.gov study NCT01055301. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.